The latest study on Radiopharmaceuticals in Nuclear Medical Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global XXX Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Radiopharmaceuticals in Nuclear Medical and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Bracco Imaging
Cambridge Isotope Laboratories
Cardinal Health
Covidien
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries
Radiopharmaceuticals in Nuclear Medical Market Analysis By Type Segment:
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
Radiopharmaceuticals in Nuclear Medical Market Analysis By Application Segment:
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Industrial
Radiopharmaceuticals in Nuclear Medical Market Analysis By Regions (Countries):-
The Radiopharmaceuticals in Nuclear Medical Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Radiopharmaceuticals in Nuclear Medical Report:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Radiopharmaceuticals in Nuclear Medical Market:
Radiopharmaceuticals in Nuclear Medical market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Radiopharmaceuticals in Nuclear Medical Market status and future forecast.
To present the key Radiopharmaceuticals in Nuclear Medical Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Study Coverage
1.1 Radiopharmaceuticals in Nuclear Medical Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Product
1.4.2 Diagnostic Radiopharmaceuticals
1.4.3 Therapy Radiopharmaceuticals
1.4.4 Enriched Stable Isotopes
1.5 Market by End User
1.5.1 Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by End User
1.5.2 Diagnostic Application
1.5.3 Therapeutic Application
1.5.4 Research
1.5.5 Pharmaceutical
1.5.6 Industrial
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceuticals in Nuclear Medical Market Size
2.1.1 Global Radiopharmaceuticals in Nuclear Medical Revenue 2016-2027
2.1.2 Global Radiopharmaceuticals in Nuclear Medical Sales 2016-2027
2.2 Radiopharmaceuticals in Nuclear Medical Growth Rate by Regions
2.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Regions
2.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Radiopharmaceuticals in Nuclear Medical Sales by Manufacturers
3.1.1 Radiopharmaceuticals in Nuclear Medical Sales by Manufacturers
3.1.2 Radiopharmaceuticals in Nuclear Medical Sales Market Share by Manufacturers
3.1.3 Global Radiopharmaceuticals in Nuclear Medical Market Concentration Ratio (CR5 and HHI)
3.2 Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers
3.2.1 Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers (2016-2020)
3.2.2 Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2016-2020)
3.3 Radiopharmaceuticals in Nuclear Medical Price by Manufacturers
3.4 Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution, Product Types
3.4.1 Radiopharmaceuticals in Nuclear Medical Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
3.4.3 Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medical Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Product
4.2 Global Radiopharmaceuticals in Nuclear Medical Revenue by Product
4.3 Radiopharmaceuticals in Nuclear Medical Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Radiopharmaceuticals in Nuclear Medical Breakdown Data by End User
6 North America
6.1 North America Radiopharmaceuticals in Nuclear Medical by Countries
6.1.1 North America Radiopharmaceuticals in Nuclear Medical Sales by Countries
6.1.2 North America Radiopharmaceuticals in Nuclear Medical Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Radiopharmaceuticals in Nuclear Medical by Product
6.3 North America Radiopharmaceuticals in Nuclear Medical by End User
7 Europe
7.1 Europe Radiopharmaceuticals in Nuclear Medical by Countries
7.1.1 Europe Radiopharmaceuticals in Nuclear Medical Sales by Countries
7.1.2 Europe Radiopharmaceuticals in Nuclear Medical Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Radiopharmaceuticals in Nuclear Medical by Product
7.3 Europe Radiopharmaceuticals in Nuclear Medical by End User
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical by Countries
8.1.1 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Countries
8.1.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Radiopharmaceuticals in Nuclear Medical by Product
8.3 Asia Pacific Radiopharmaceuticals in Nuclear Medical by End User
9 Central & South America
9.1 Central & South America Radiopharmaceuticals in Nuclear Medical by Countries
9.1.1 Central & South America Radiopharmaceuticals in Nuclear Medical Sales by Countries
9.1.2 Central & South America Radiopharmaceuticals in Nuclear Medical Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Radiopharmaceuticals in Nuclear Medical by Product
9.3 Central & South America Radiopharmaceuticals in Nuclear Medical by End User
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical by Countries
10.1.1 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Countries
10.1.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Radiopharmaceuticals in Nuclear Medical by Product
10.3 Middle East and Africa Radiopharmaceuticals in Nuclear Medical by End User
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Company Details
11.1.2 Company Business Overview
11.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.1.4 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
11.1.5 Bracco Imaging Recent Development
11.2 Cambridge Isotope Laboratories
11.2.1 Cambridge Isotope Laboratories Company Details
11.2.2 Company Business Overview
11.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.2.4 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Products Offered
11.2.5 Cambridge Isotope Laboratories Recent Development
11.3 Cardinal Health
11.3.1 Cardinal Health Company Details
11.3.2 Company Business Overview
11.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.3.4 Cardinal Health Radiopharmaceuticals in Nuclear Medical Products Offered
11.3.5 Cardinal Health Recent Development
11.4 Covidien
11.4.1 Covidien Company Details
11.4.2 Company Business Overview
11.4.3 Covidien Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.4.4 Covidien Radiopharmaceuticals in Nuclear Medical Products Offered
11.4.5 Covidien Recent Development
11.5 Eczacibasi-Monrol
11.5.1 Eczacibasi-Monrol Company Details
11.5.2 Company Business Overview
11.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.5.4 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Products Offered
11.5.5 Eczacibasi-Monrol Recent Development
11.6 Fujifilm Holdings Corporation
11.6.1 Fujifilm Holdings Corporation Company Details
11.6.2 Company Business Overview
11.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.6.4 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Products Offered
11.6.5 Fujifilm Holdings Corporation Recent Development
11.7 GE Healthcare (Subsidiary Of General Electric Company)
11.7.1 GE Healthcare (Subsidiary Of General Electric Company) Company Details
11.7.2 Company Business Overview
11.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.7.4 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Products Offered
11.7.5 GE Healthcare (Subsidiary Of General Electric Company) Recent Development
11.8 IBA Group
11.8.1 IBA Group Company Details
11.8.2 Company Business Overview
11.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.8.4 IBA Group Radiopharmaceuticals in Nuclear Medical Products Offered
11.8.5 IBA Group Recent Development
11.9 Lantheus Medical Imaging
11.9.1 Lantheus Medical Imaging Company Details
11.9.2 Company Business Overview
11.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.9.4 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Products Offered
11.9.5 Lantheus Medical Imaging Recent Development
11.10 Nordion
11.10.1 Nordion Company Details
11.10.2 Company Business Overview
11.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue and Gross Margin (2019-2020)
11.10.4 Nordion Radiopharmaceuticals in Nuclear Medical Products Offered
11.10.5 Nordion Recent Development
11.11 Ntp Radioisotopes
11.12 Siemens Healthcare
11.13 Taiyo Nippon Sanso Corporation
11.14 Urenco Limited
11.15 Rotem Industries
12 Future Forecast
12.1 Radiopharmaceuticals in Nuclear Medical Market Forecast by Regions
12.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Regions 2021-2027
12.1.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Regions 2021-2027
12.2 Radiopharmaceuticals in Nuclear Medical Market Forecast by Product
12.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Product 2021-2027
12.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Product 2021-2027
12.3 Radiopharmaceuticals in Nuclear Medical Market Forecast by End User
12.4 North America Radiopharmaceuticals in Nuclear Medical Forecast
12.5 Europe Radiopharmaceuticals in Nuclear Medical Forecast
12.6 Asia Pacific Radiopharmaceuticals in Nuclear Medical Forecast
12.7 Central & South America Radiopharmaceuticals in Nuclear Medical Forecast
12.8 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Radiopharmaceuticals in Nuclear Medical Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
List of Tables and Figures
Figure Radiopharmaceuticals in Nuclear Medical Product Picture
Table Radiopharmaceuticals in Nuclear Medical Market Segments
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medical Covered
Table Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by Product 2021-2027 (K Units) & (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product 2016-2027
Figure Diagnostic Radiopharmaceuticals Product Picture
Table Major Manufacturers of Diagnostic Radiopharmaceuticals
Figure Therapy Radiopharmaceuticals Product Picture
Table Major Manufacturers of Therapy Radiopharmaceuticals
Figure Enriched Stable Isotopes Product Picture
Table Major Manufacturers of Enriched Stable Isotopes
Table Global Radiopharmaceuticals in Nuclear Medical Market Size Growth Rate by End User 2021-2027 (K Units)
Figure Diagnostic Application
Figure Therapeutic Application
Figure Research
Figure Pharmaceutical
Figure Industrial
Figure Radiopharmaceuticals in Nuclear Medical Report Years Considered
Figure Global Radiopharmaceuticals in Nuclear Medical Market Size 2016-2027 (Million US$)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales 2016-2027 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Market Size by Regions 2016-2020 (K Units) & (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Sales by Regions 2016-2020 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Regions 2016-2020
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Regions 2016-2020
Figure 2020 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Regions
Table Global Radiopharmaceuticals in Nuclear Medical Revenue by Regions 2016-2020 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions 2016-2020
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions 2016-2020
Figure 2020 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Regions
Table Global Radiopharmaceuticals in Nuclear Medical Sales by Manufacturers (2019-2020) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Share by Manufacturers (2019-2020)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Share by Manufacturers in 2020
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Radiopharmaceuticals in Nuclear Medical Revenue by Manufacturers (2019-2020) (Million USD)
Table Radiopharmaceuticals in Nuclear Medical Revenue Share by Manufacturers (2019-2020)
Figure Radiopharmaceuticals in Nuclear Medical Value Share by Manufacturers in 2020
Table Key Manufacturers Radiopharmaceuticals in Nuclear Medical Price (2016-2020) (USD/Unit)
Table Radiopharmaceuticals in Nuclear Medical Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Radiopharmaceuticals in Nuclear Medical Product Type
Table Date of International Manufacturers Enter into Radiopharmaceuticals in Nuclear Medical Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Radiopharmaceuticals in Nuclear Medical Sales by Product (2016-2020) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Share by Product (2016-2020)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2016-2020)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product in 2020
Table Global Radiopharmaceuticals in Nuclear Medical Revenue by Product (2016-2020) (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Share by Product (2016-2020)
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Product (2016-2020)
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Product in 2020
Table Radiopharmaceuticals in Nuclear Medical Price by Product 2016-2020 (USD/Unit)
Table Global Radiopharmaceuticals in Nuclear Medical Sales by End User (2016-2020) (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Share by End User (2016-2020)
Figure Global Sales Radiopharmaceuticals in Nuclear Medical Market Share by End User (2016-2020)
Figure Global Sales Radiopharmaceuticals in Nuclear Medical Market Share by End User in 2020
Figure North America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2016-2020 (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2016-2020 (Million US$)
Table North America Radiopharmaceuticals in Nuclear Medical Sales by Countries (2016-2020) (K Units)
Table North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2016-2020)
Figure 2020 North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table North America Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2016-2020) (Million US$)
Table North America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2016-2020)
Figure 2020 North America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure United States Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure United States Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (K Units)
Figure Canada Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Canada Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Mexico Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Mexico Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Table North America Radiopharmaceuticals in Nuclear Medical Sales by Product (2016-2020) (K Units)
Table North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2016-2020)
Figure 2020 North America Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table North America Radiopharmaceuticals in Nuclear Medical Sales by End User (2016-2020) (K Units)
Table North America Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2016-2020)
Figure 2020 North America Radiopharmaceuticals in Nuclear Medical Market Share by End User
Figure Europe Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2016-2020 (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2016-2020 (Million US$)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales by Countries (2016-2020) (K Units)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2016-2020)
Figure 2020 Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table Europe Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2016-2020) (Million US$)
Table Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2016-2020)
Figure 2020 Europe Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure Germany Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Germany Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure France Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure France Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure UK Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure UK Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Italy Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Italy Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Russia Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Russia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales by Product (2016-2020) (K Units)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2016-2020)
Figure 2020 Europe Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table Europe Radiopharmaceuticals in Nuclear Medical Sales by End User (2016-2020) (K Units)
Table Europe Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2016-2020)
Figure 2020 Europe Radiopharmaceuticals in Nuclear Medical Market Share by End User
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2016-2020 (K Units)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2016-2020 (Million US$)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Countries (2016-2020) (K Units)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2016-2020)
Figure 2020 Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2016-2020) (Million US$)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2016-2020)
Figure 2020 Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure China Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure China Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Japan Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Japan Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Korea Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Korea Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure India Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure India Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Australia Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Australia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Indonesia Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Indonesia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Malaysia Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Malaysia Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Philippines Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Philippines Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Thailand Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Thailand Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Vietnam Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Vietnam Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Singapore Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Singapore Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by Product (2016-2020) (K Units)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2016-2020)
Figure 2020 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales by End User (2016-2020) (K Units)
Table Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2016-2020)
Figure 2020 Asia Pacific Radiopharmaceuticals in Nuclear Medical Market Share by End User
Figure Central & South America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2016-2020 (K Units)
Figure Central & South America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2016-2020 (Million US$)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales by Countries (2016-2020) (K Units)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2016-2020)
Figure 2020 Central & South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table Central & South America Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2016-2020) (Million US$)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2016-2020)
Figure 2020 Central & South America Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure Brazil Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Brazil Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Argentina Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Argentina Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales by Product (2016-2020) (K Units)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2016-2020)
Figure 2020 Central & South America Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales by End User (2016-2020) (K Units)
Table Central & South America Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2016-2020)
Figure 2020 Central & South America Radiopharmaceuticals in Nuclear Medical Market Share by End User
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Growth Rate 2016-2020 (K Units)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate 2016-2020 (Million US$)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Countries (2016-2020) (K Units)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries (2016-2020)
Figure 2020 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Countries
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue by Countries (2016-2020) (Million US$)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries (2016-2020)
Figure 2020 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue Market Share by Countries
Figure GCC Countries Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure GCC Countries Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Turkey Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Turkey Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure Egypt Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure Egypt Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Figure South Africa Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2016-2020) (K Units)
Figure South Africa Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate (2016-2020) (Million US$)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by Product (2016-2020) (K Units)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by Product (2016-2020)
Figure 2020 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Share by Product
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales by End User (2016-2020) (K Units)
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Market Share by End User (2016-2020)
Figure 2020 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Market Share by End User
Table Bracco Imaging Company Details
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table Bracco Imaging Recent Development
Table Cambridge Isotope Laboratories Company Details
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table Cambridge Isotope Laboratories Recent Development
Table Cardinal Health Company Details
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table Cardinal Health Recent Development
Table Covidien Company Details
Table Covidien Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table Covidien Recent Development
Table Eczacibasi-Monrol Company Details
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table Eczacibasi-Monrol Recent Development
Table Fujifilm Holdings Corporation Company Details
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table Fujifilm Holdings Corporation Recent Development
Table GE Healthcare (Subsidiary Of General Electric Company) Company Details
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table GE Healthcare (Subsidiary Of General Electric Company) Recent Development
Table IBA Group Company Details
Table IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table IBA Group Recent Development
Table Lantheus Medical Imaging Company Details
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table Lantheus Medical Imaging Recent Development
Table Nordion Company Details
Table Nordion Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2020)
Table Nordion Recent Development
Table Ntp Radioisotopes Company Details
Table Siemens Healthcare Company Details
Table Taiyo Nippon Sanso Corporation Company Details
Table Urenco Limited Company Details
Table Rotem Industries Company Details
Table Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Regions 2021-2027 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Regions 2021-2027
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Regions 2021-2027 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Regions 2021-2027
Table Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Product 2021-2027 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by Product 2021-2027
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Forecast by Product 2021-2027 (Million US$)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share Forecast by Product 2021-2027
Table Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by End User 2021-2027 (K Units)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Market Share Forecast by End User 2021-2027
Figure North America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2021-2027) (K Units)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Europe Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2021-2027) (K Units)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2021-2027) (K Units)
Figure Asia Pacific Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Central & South America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2021-2027) (K Units)
Figure Central & South America Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2021-2027) (Million US$)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Growth Rate Forecast (2021-2027) (K Units)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue Growth Rate Forecast (2021-2027) (Million US$)
Table Radiopharmaceuticals in Nuclear Medical Value Chain
Table Radiopharmaceuticals in Nuclear Medical Customers List
Table Radiopharmaceuticals in Nuclear Medical Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources